Meditation and Yogic Breathing-driven Modulation of Neurofluid Coupling and Brain Clearance (SPANDHA)
This study will examine whether meditation and yogic breathing can alter brain fluid movement and waste clearance in healthy adults. It will also evaluate the GLYMPHOMETER, a new external forehead-worn device designed to objectively measure changes in brain fluid movement and exchange during meditation.
調査の概要
詳細な説明
The glymphatic system is a brain waste-clearance pathway that facilitates the movement of cerebrospinal fluid (CSF) and interstitial fluid and is thought to play an important role in maintaining brain homeostasis. Emerging evidence suggests that respiration, autonomic activity, and changes in cerebral blood flow may influence CSF dynamics and related neurofluid processes. However, the effects of voluntary breathing practices and meditation on these physiological mechanisms in humans remain incompletely understood.
The SPANDHA study will investigate whether structured yogic breathing (Pranayama; specifically Nadi Shuddhi) and/or meditation (Shoonya meditation) are associated with changes in neurofluid dynamics and related physiological measures. The study will use the GLYMPHOMETER, a forehead-mounted multimodal device designed to measure physiological signals associated with neurofluid coupling during naturalistic meditation and breathing practices. The system incorporates multi-wavelength electroencephalography (EEG) and near-infrared spectroscopy (NIRS) to characterize changes in cerebral electrical activity, cerebral hemodynamics, and neurofluid-related dynamics while participants engage in the interventions.
The study will enroll approximately 100 participants, including 50 novice and 50 experienced practitioners. Using a 2-sequence crossover, participants will complete two study visits involving meditation and yogic breathing conditions. The study will evaluate changes in measures of neurofluid dynamics, cerebral compliance, autonomic regulation including heart-rate variability (HRV), and EEG-derived brain states associated with the interventions. Participants will be stratified by experience level (novice/advance) and randomized within each stratum to one of the two intervention sequences.
A subset of participants will undergo additional validation assessments using phase-contrast magnetic resonance imaging (MRI) and blood-based biomarkers. These assessments will be used to examine the relationship between measurements obtained with the GLYMPHOMETER and established measures of CSF and cerebrovascular physiology.
The primary objective of the study is to characterize the acute physiological effects of meditation and yogic breathing on neurofluid dynamics and related brain and autonomic measures. The findings may provide preliminary evidence regarding the feasibility of using voluntary breathing and meditation practices to modulate physiological processes associated with glymphatic function and may inform future studies of non-pharmacological approaches to brain health.
研究の種類
入学 (推定)
段階
- 適用できない
連絡先と場所
研究連絡先
- 名前:Balachundhar Subramaniam, MD MPH
- 電話番号:(781) 472-0572
- メール:bsubrama@bidmc.harvard.edu
研究場所
-
-
Massachusetts
-
Boston、Massachusetts、アメリカ、02215
- BIDMC
-
コンタクト:
- Deepthi R Johal, PhD
- 電話番号:8574263244
- メール:drajashe@bidmc.harvard.edu
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
Inclusion Criteria:
- Healthy adults, 25-60 years old.
- Novice or Advanced as defined above.
- Fluent in English.
- Able to travel to BIDMC site for two days approximately 3-7 days apart.
Exclusion Criteria:
- History of neurological and/or neurodegenerative disorders (e.g., epilepsy, stroke, mild cognitive impairment, dementia)
- History of cardiovascular and respiratory illnesses
- History of major psychiatric disorders (e.g., schizophrenia, bipolar disorder)
- Currently diagnosed mental health issues (e.g., anxiety, depression)
- Current use of psychoactive medications, including medications prescribed for anxiety, depression, or other psychiatric conditions, or current use of stimulants or other medications that may substantially affect central nervous system function or study outcomes.
- Skin ailments, abrasions or contusions, particularly located on the forehead and face
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:他の
- 割り当て:非ランダム化
- 介入モデル:クロスオーバー割り当て
- マスキング:なし(オープンラベル)
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
アクティブコンパレータ:Novice Meditators
Less than 1 year of consistent meditation practice. |
Nadi Shuddhi is a structured yogic breathing practice involving slow, alternating respiration through the left and right nostrils in a prescribed sequence. Shoonya meditation is a structured contemplative practice characterized by conscious non-doing, in which participants maintain a relaxed, alert state while minimizing deliberate attentional selection, cognitive elaboration, and engagement with internal or external stimuli. |
|
アクティブコンパレータ:Advanced Meditators
More than 5 years or a minimum of 2500 hours of consistent meditation practice |
Nadi Shuddhi is a structured yogic breathing practice involving slow, alternating respiration through the left and right nostrils in a prescribed sequence. Shoonya meditation is a structured contemplative practice characterized by conscious non-doing, in which participants maintain a relaxed, alert state while minimizing deliberate attentional selection, cognitive elaboration, and engagement with internal or external stimuli. |
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Acquisition of physiological data using the GLYMPHOMETER during meditation and yogic breathing sessions.
時間枠:At each study visit while the meditation is being practiced. Expected acquisition window: 20 minutes; Total number of visits: 2
|
Participants meeting threshold for analyzable device recordings. |
At each study visit while the meditation is being practiced. Expected acquisition window: 20 minutes; Total number of visits: 2
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Neurofluid-related physiological measures during Shoonya meditation and Nadi Shuddhi breathing.
時間枠:At each study visit while the meditation is being practiced. Expected acquisition window: 20 minutes; Total number of visits: 2
|
Changes in GLYMPHOMETER-derived measures of neurofluid coupling, during Shoonya meditation and Nadi Shuddhi breathing. (Measurement device: Glymphometer; Measure: Neurofluid coupling aka Fluid dynamics in brain) |
At each study visit while the meditation is being practiced. Expected acquisition window: 20 minutes; Total number of visits: 2
|
|
Autonomic regulation during Shoonya meditation and Nadi Shuddhi breathing.
時間枠:At each study visit while the meditation is being practiced. Expected acquisition window: 20 minutes; Total number of visits: 2
|
Changes in heart-rate variability (HRV) during Shoonya meditation and Nadi Shuddhi breathing. |
At each study visit while the meditation is being practiced. Expected acquisition window: 20 minutes; Total number of visits: 2
|
|
Very-low-frequency physiological signal characteristics
時間枠:At each study visit while the meditation is being practiced. Expected acquisition window: 20 minutes; Total number of visits: 2
|
Changes in predefined very-low-frequency (0.001-0.1 Hz) signal characteristics derived from GLYMPHOMETER medical™ recordings and their relationship to neurofluid-related measures. |
At each study visit while the meditation is being practiced. Expected acquisition window: 20 minutes; Total number of visits: 2
|
その他の成果指標
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Differences in neurophysiological responses according to meditation experience.
時間枠:From date of enrollment until end of both study visits; assessed up to 4 weeks from enrollment.
|
Comparison of changes in GLYMPHOMETER-derived measures of neurofluid coupling between novice and advanced meditators. |
From date of enrollment until end of both study visits; assessed up to 4 weeks from enrollment.
|
|
Mindful Attention Awareness Scale
時間枠:Once at Baseline. Estimated acquisition window: 5-8 minutes
|
We assess for change in Mindfulness levels by using a validated scale for this purpose namely, Mindfulness Attention Awareness Scale (MAAS). The scale measures the individuals' ability for receptive awareness and attention to present. This aids in evaluating any change on the individual's awareness levels after the Inner engineering intervention. We compute the MAAS scores for each participant which is a mean score for 15 item questionnaires and compare the pre & post intervention results to look for change. Participants are asked to rate on a scale of 1 (Almost Always) to 6 (Almost Never) to assess the frequency of occurrence of each experience. Mean is then computed using items from each of the 15 questions to create a MAAS score, ranging from 0 to 6. Higher MAAS scores indicate better mindfulness state. |
Once at Baseline. Estimated acquisition window: 5-8 minutes
|
|
Meditation Depth Questionnaires
時間枠:At each study visit after the meditation practice is completed. Expected acquisition window: 10-15 minutes; Total number of visits: 2
|
This 30-item measure assesses the subjective depth of meditation across progressively deeper experiential states. Items are typically rated on a 5-point Likert scale and are grouped into five empirically derived domains: hindrances, relaxation, personal-self/concentration, essential/transpersonal qualities, and transpersonal-self/non-duality. Together, these domains capture experiences ranging from obstacles and relaxation during meditation to focused concentration, transpersonal qualities, and experiences of diminished self-boundaries or non-dual awareness. |
At each study visit after the meditation practice is completed. Expected acquisition window: 10-15 minutes; Total number of visits: 2
|
|
Correlation between GLYMPHOMETER-derived neurofluid metrics and MRI-based neurofluid dynamics (Validation of Portable Device).
時間枠:From date of enrollment until end of both study visits; assessed up to 4 weeks from enrollment.
|
This outcome evaluates the concurrent validity of the portable device against the gold standard. The statistical method will be a correlation analysis (Pearson or Spearman, as appropriate based on data distribution).
|
From date of enrollment until end of both study visits; assessed up to 4 weeks from enrollment.
|
|
Correlation between GLYMPHOMETER-derived neurofluid metrics and plasma brain-derived biomarkers.
時間枠:From date of enrollment until end of both study visits; assessed up to 4 weeks from enrollment.
|
This outcome evaluates the relationship between neurofluid dynamics and blood-based markers of brain clearance. The statistical method will be a correlation analysis (Pearson or Spearman).
|
From date of enrollment until end of both study visits; assessed up to 4 weeks from enrollment.
|
|
Qualitative assessment of meditation and breathing experiences.
時間枠:At each study visit after the meditation practice is completed. Expected acquisition window: 30 minutes; Total number of visits: 2
|
Qualitative characterization of participant experiences using one-on-one micro-phenomenological interviews. |
At each study visit after the meditation practice is completed. Expected acquisition window: 30 minutes; Total number of visits: 2
|
協力者と研究者
研究記録日
主要日程の研究
研究開始 (推定)
一次修了 (推定)
研究の完了 (推定)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
キーワード
その他の研究ID番号
- 2026P000655
- GRT69415 (その他の助成金/資金番号:Inner Science Research Foundation)
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。